Shu-Juan Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shu-Juan Sun has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Dajian Gu
1 shared publicationGuo-Ren Yang
1 shared publicationHong-Jian Li
1 shared publicationHongjian Li
1 shared publicationJie Sun
1 shared publicationJun Li
1 shared publication
Latest Publications
- 1 October 2006
- Vol. 41 (10) , 927-32
Colon-specific delivery tablets of sodium 4-aminosalicylic acid.
To prepare a new oral colon-specific delivery formulation and to investigate the release profile in vitro and the colon-specific delivery property in vivo in dogs. Sodium 4-aminosalicylic acid was selected as the model drug. The combination of Eudragit RL30D and RS30D were used as sustained-release film, and Eudragit FS30D used as enteric film, which was expected to release drug depending on pH and time. The release profile of tablets was studied in three phosphate buffers with the pH 6.5, 7.0 or 7.4 for 12 h after a simulated gastric presoak for 2 h in 0.1 mol x L(-1) HCl. The tablets were radiolabelled with 99mTc to make their release times and positions in the gastrointestinal tract be followed using a gamma camera. For the in vitro study, there was no drug released in 0.1 mol x L(-1) HCl for 2 h, and release occurred slowly when pH was above 6.5. Drug was released faster while pH was higher. For the in vivo study, the coated tablets remained intact in the upper gastrointestinal tract, and drug release began after the colonic arrival. The uncoated tablets, however, disintegrated in the stomach of the dogs rapidly. The coating could protect the drug until the tablets reached the ascending colon, where drug was released slowly for over 10 h.
- 1 October 2006
- Vol. 41 (10) , 927-32
Colon-specific delivery tablets of sodium 4-aminosalicylic acid.
To prepare a new oral colon-specific delivery formulation and to investigate the release profile in vitro and the colon-specific delivery property in vivo in dogs. Sodium 4-aminosalicylic acid was selected as the model drug. The combination of Eudragit RL30D and RS30D were used as sustained-release film, and Eudragit FS30D used as enteric film, which was expected to release drug depending on pH and time. The release profile of tablets was studied in three phosphate buffers with the pH 6.5, 7.0 or 7.4 for 12 h after a simulated gastric presoak for 2 h in 0.1 mol x L(-1) HCl. The tablets were radiolabelled with 99mTc to make their release times and positions in the gastrointestinal tract be followed using a gamma camera. For the in vitro study, there was no drug released in 0.1 mol x L(-1) HCl for 2 h, and release occurred slowly when pH was above 6.5. Drug was released faster while pH was higher. For the in vivo study, the coated tablets remained intact in the upper gastrointestinal tract, and drug release began after the colonic arrival. The uncoated tablets, however, disintegrated in the stomach of the dogs rapidly. The coating could protect the drug until the tablets reached the ascending colon, where drug was released slowly for over 10 h.
- 1 September 2006
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 42 (2) , 218-222
Study on warfarin plasma concentration and its correlation with international normalized ratio
- 1 September 2006
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 42 (2) , 218-222
Study on warfarin plasma concentration and its correlation with international normalized ratio